GLP-1 Digest

GLP-1 Digest

Home
Podcast
Archive
Leaderboard
About
🎧 GLP-1s Are Coming for the Snack Aisle, Ep. 5 with Henry Dimbleby
On shrinking food volumes, and why consumers want more value per bite
 • Ashwin Sharma, MD
53:37
What happens when GLP-1s go off-patent?
Five charts that’ve caught my eye
 • Ashwin Sharma, MD
🎧 Can GLP-1s Save the NHS? Ep. 4 with Lord James Bethell
Healthspan is decreasing in the UK, and the private market could help turn things around
 • Ashwin Sharma, MD
41:12
India is not the opportunity you think it is
Why DTC telehealth won't work in India's GLP-1 market
 • Ashwin Sharma, MD
🎧 Should GLP-1s be sold over the counter? Ep 3, with Dr. Beverly Tchang, MD
On the maintenance trap, microdosing for prevention, and frictionless access
 • Ashwin Sharma, MD
1:19:22
🎧 What investors get wrong about Hims & Hers, Ep. 2 with Paul Cerro
Listen now | The definitive Q4 2025 earnings breakdown
 • Ashwin Sharma, MD
1:09:46
🎧 The GLP-1 business model problem, Ep. 1 with Prof. Alex Miras
Why the drug does the heavy lifting, price trumps everything, and muscle loss might not be what we think
 • Ashwin Sharma, MD
1:09:43
GLP-1 Digest
GLP-1 Digest
The GLP-1 newsletter for founders, operators and investors.
Recommendations
View all 6
Big Pharma Sharma
Big Pharma Sharma
Big Pharma Sharma
The Argument
The Argument
The Argument
The Device Files: From Concept to Commercialization
The Device Files: From Concept to Commercialization
Blythe Karow
The Gut Group
The Gut Group
Dr Arif Hussenbux MBBS
Breakthrough
Breakthrough
Samuel Hume

GLP-1 Digest

AboutArchiveRecommendationsSitemap
© 2026 Ashwin Sharma · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture